Autoimmune polyendocrinopathy-candidiasis-ectodermal dysplasia (APECED), also known as autoimmune polyglandular syndrome type 1, has an estimated prevalence of 2.6–10 cases per million people and a heterogeneous clinical presentation. The classic triad includes hypoparathyroidism, adrenal insufficiency, and chronic mucocutaneous candidiasis (CMC). Hypoparathyroidism, the most common endocrine manifestation of this disorder, remains difficult to treat.
Autoren
- Jens Dehn
Publikation
- InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
You May Also Like
- Endocrinology: APECED-Associated Hypoparathyroidism
A parathyroid hormone analog corrected serum calcium levels
- Transient ischemic attack
Comprehensive diagnostic testing can reduce the risk of stroke
- Malignant Tumors of the Clavicle
Surgical Challenges and Recurrence Patterns
- Chronic hand eczema: common, long-lasting, and distressing
Non-steroidal anti-inflammatory treatment options are essential for long-term management
- Alcohol Consumption While Taking Semaglutide
Withdrawal Symptoms Thanks to GLP-1 RA?
- Non-anginal chest pain: Could it be a heart attack?
From Triage to Secondary Prevention—A Recent Update
- Malignant oral squamous cell carcinomas (OPSCC/HNSCC)
Innovative Treatment Options
- Acne vulgaris: Topical and Systemic Treatment Options